Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 25 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

5 trials in Phase 3/4

Results Transparency

15%

2 of 13 completed trials have results

Key Signals

5 recruiting2 with results

Enrollment Performance

Analytics

N/A

8(47.1%)

Phase 4

4(23.5%)

Phase 2

4(23.5%)

Phase 3

1(5.9%)

17Total

N/A(8)

Phase 4(4)

Phase 2(4)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (26)

Showing 20 of 26 trials

NCT07574619Not ApplicableNot Yet Recruiting

Improving Choice And Use Of Biomedical HIV Prevention For Women In Uganda: A Couples-based Approach

Role: collaborator

NCT06833957Recruiting

Preparing for Maternal GBS Vaccine Trials in Africa

Role: collaborator

NCT04337450Phase 2Active Not Recruiting

DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old

Role: collaborator

NCT03737669Phase 3Completed

Mirasol Evaluation of Reduction in Infections Trial

Role: collaborator

NCT07173764Not Yet Recruiting

Congenital and Maternal Point of Care Rapid Testing for Syphilis Study, Uganda

Role: collaborator

NCT07097961Not ApplicableRecruiting

Paediatric Post-TB Pulmonary Rehab Study

Role: collaborator

NCT06474364Phase 4Recruiting

HIV Prevention and Care Interventions for Youth in Uganda

Role: lead

NCT04664998Phase 4Completed

Alignment of PrEP Use With HIV Risk in Young Women and Men

Role: collaborator

NCT03878147Not ApplicableCompleted

Neurodevelopmental Assessment of Children in Uganda and Malawi Using a Software Package

Role: collaborator

NCT04549220Active Not Recruiting

Serosurveillance Study of Maternally Derived Anti-GBS Antibody

Role: collaborator

NCT06667206Phase 2Recruiting

Earlier Prime-BOOST Schedule to Improve MEasles Protection in High Burden Settings

Role: collaborator

NCT03464266Phase 4Completed

The Kampala Women's Bone Study

Role: collaborator

NCT06411405Recruiting

Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe

Role: collaborator

NCT05832502Phase 2Unknown

Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Role: collaborator

NCT04653948Unknown

Maternal, Neonatal and Infant Outcomes at Kawempe National Referral Hospital

Role: collaborator

NCT04589312Phase 2Completed

Maternal Pertussis Wholecell Responses

Role: collaborator

NCT05409274Completed

Understanding COVID-19 Infections in Pregnant Women and Their Babies in 5 African Nations (periCOVID Africa)

Role: collaborator

NCT04732026Unknown

Serocorrelate of Protection Against GBS (PREPARE WP3)

Role: collaborator

NCT03916328Phase 4Unknown

BONE: STAR (Switching to TAF Based Anti-Retroviral Therapy) Study

Role: lead

NCT02515370Not ApplicableCompleted

Friends for Life Circles for Option B Plus

Role: lead